2022-04-012023-03-312023-03-31false13305220ROSE TREE SURGEONS LIMITED2023-09-2281300iso4217:GBPxbrli:pure133052202022-04-01133052202023-03-31133052202022-04-012023-03-31133052202021-03-31133052202022-03-31133052202021-03-312022-03-3113305220bus:SmallEntities2022-04-012023-03-3113305220bus:AuditExempt-NoAccountantsReport2022-04-012023-03-3113305220bus:FullAccounts2022-04-012023-03-3113305220bus:PrivateLimitedCompanyLtd2022-04-012023-03-3113305220core:WithinOneYear2023-03-3113305220core:AfterOneYear2023-03-3113305220core:WithinOneYear2022-03-3113305220core:AfterOneYear2022-03-3113305220core:ShareCapital2023-03-3113305220core:SharePremium2023-03-3113305220core:RevaluationReserve2023-03-3113305220core:OtherReservesSubtotal2023-03-3113305220core:RetainedEarningsAccumulatedLosses2023-03-3113305220core:ShareCapital2022-03-3113305220core:SharePremium2022-03-3113305220core:RevaluationReserve2022-03-3113305220core:OtherReservesSubtotal2022-03-3113305220core:RetainedEarningsAccumulatedLosses2022-03-3113305220core:LandBuildings2023-03-3113305220core:PlantMachinery2023-03-3113305220core:Vehicles2023-03-3113305220core:FurnitureFittings2023-03-3113305220core:OfficeEquipment2023-03-3113305220core:NetGoodwill2023-03-3113305220core:IntangibleAssetsOtherThanGoodwill2023-03-3113305220core:ListedExchangeTraded2023-03-3113305220core:UnlistedNon-exchangeTraded2023-03-3113305220core:LandBuildings2022-03-3113305220core:PlantMachinery2022-03-3113305220core:Vehicles2022-03-3113305220core:FurnitureFittings2022-03-3113305220core:OfficeEquipment2022-03-3113305220core:NetGoodwill2022-03-3113305220core:IntangibleAssetsOtherThanGoodwill2022-03-3113305220core:ListedExchangeTraded2022-03-3113305220core:UnlistedNon-exchangeTraded2022-03-3113305220core:LandBuildings2022-04-012023-03-3113305220core:PlantMachinery2022-04-012023-03-3113305220core:Vehicles2022-04-012023-03-3113305220core:FurnitureFittings2022-04-012023-03-3113305220core:OfficeEquipment2022-04-012023-03-3113305220core:NetGoodwill2022-04-012023-03-3113305220core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113305220core:ListedExchangeTraded2022-04-012023-03-3113305220core:UnlistedNon-exchangeTraded2022-04-012023-03-3113305220core:MoreThanFiveYears2022-04-012023-03-3113305220core:Non-currentFinancialInstruments2023-03-3113305220core:Non-currentFinancialInstruments2022-03-3113305220dpl:CostSales2022-04-012023-03-3113305220dpl:DistributionCosts2022-04-012023-03-3113305220dpl:AdministrativeExpenses2022-04-012023-03-3113305220core:LandBuildings2022-04-012023-03-3113305220core:PlantMachinery2022-04-012023-03-3113305220core:Vehicles2022-04-012023-03-3113305220core:FurnitureFittings2022-04-012023-03-3113305220core:OfficeEquipment2022-04-012023-03-3113305220core:NetGoodwill2022-04-012023-03-3113305220core:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3113305220dpl:GroupUndertakings2022-04-012023-03-3113305220dpl:ParticipatingInterests2022-04-012023-03-3113305220dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-012023-03-3113305220core:ListedExchangeTraded2022-04-012023-03-3113305220dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-012023-03-3113305220core:UnlistedNon-exchangeTraded2022-04-012023-03-3113305220dpl:CostSales2021-03-312022-03-3113305220dpl:DistributionCosts2021-03-312022-03-3113305220dpl:AdministrativeExpenses2021-03-312022-03-3113305220core:LandBuildings2021-03-312022-03-3113305220core:PlantMachinery2021-03-312022-03-3113305220core:Vehicles2021-03-312022-03-3113305220core:FurnitureFittings2021-03-312022-03-3113305220core:OfficeEquipment2021-03-312022-03-3113305220core:NetGoodwill2021-03-312022-03-3113305220core:IntangibleAssetsOtherThanGoodwill2021-03-312022-03-3113305220dpl:GroupUndertakings2021-03-312022-03-3113305220dpl:ParticipatingInterests2021-03-312022-03-3113305220dpl:GroupUndertakingscore:ListedExchangeTraded2021-03-312022-03-3113305220core:ListedExchangeTraded2021-03-312022-03-3113305220dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2021-03-312022-03-3113305220core:UnlistedNon-exchangeTraded2021-03-312022-03-3113305220core:NetGoodwill2023-03-3113305220core:IntangibleAssetsOtherThanGoodwill2023-03-3113305220core:LandBuildings2023-03-3113305220core:PlantMachinery2023-03-3113305220core:Vehicles2023-03-3113305220core:FurnitureFittings2023-03-3113305220core:OfficeEquipment2023-03-3113305220core:AfterOneYear2023-03-3113305220core:WithinOneYear2023-03-3113305220core:ListedExchangeTraded2023-03-3113305220core:UnlistedNon-exchangeTraded2023-03-3113305220core:ShareCapital2023-03-3113305220core:SharePremium2023-03-3113305220core:RevaluationReserve2023-03-3113305220core:OtherReservesSubtotal2023-03-3113305220core:RetainedEarningsAccumulatedLosses2023-03-3113305220core:NetGoodwill2022-03-3113305220core:IntangibleAssetsOtherThanGoodwill2022-03-3113305220core:LandBuildings2022-03-3113305220core:PlantMachinery2022-03-3113305220core:Vehicles2022-03-3113305220core:FurnitureFittings2022-03-3113305220core:OfficeEquipment2022-03-3113305220core:AfterOneYear2022-03-3113305220core:WithinOneYear2022-03-3113305220core:ListedExchangeTraded2022-03-3113305220core:UnlistedNon-exchangeTraded2022-03-3113305220core:ShareCapital2022-03-3113305220core:SharePremium2022-03-3113305220core:RevaluationReserve2022-03-3113305220core:OtherReservesSubtotal2022-03-3113305220core:RetainedEarningsAccumulatedLosses2022-03-3113305220core:NetGoodwill2021-03-3113305220core:IntangibleAssetsOtherThanGoodwill2021-03-3113305220core:LandBuildings2021-03-3113305220core:PlantMachinery2021-03-3113305220core:Vehicles2021-03-3113305220core:FurnitureFittings2021-03-3113305220core:OfficeEquipment2021-03-3113305220core:AfterOneYear2021-03-3113305220core:WithinOneYear2021-03-3113305220core:ListedExchangeTraded2021-03-3113305220core:UnlistedNon-exchangeTraded2021-03-3113305220core:ShareCapital2021-03-3113305220core:SharePremium2021-03-3113305220core:RevaluationReserve2021-03-3113305220core:OtherReservesSubtotal2021-03-3113305220core:RetainedEarningsAccumulatedLosses2021-03-3113305220core:AfterOneYear2022-04-012023-03-3113305220core:WithinOneYear2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:CostValuation2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-04-012023-03-3113305220core:Non-currentFinancialInstrumentscore:CostValuation2023-03-3113305220core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-03-3113305220core:Non-currentFinancialInstrumentscore:CostValuation2022-03-3113305220core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-03-3113305220core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-03-3113305220bus:Director12022-04-012023-03-3113305220bus:Director22022-04-012023-03-31

ROSE TREE SURGEONS LIMITED

Registered Number
13305220
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2023

ROSE TREE SURGEONS LIMITED
Company Information
for the year from 1 April 2022 to 31 March 2023

Directors

ROSE, Dominic
ROSE, Gemma

Registered Address

16 Hutton Way
Woburn Sands
Milton Keynes
MK17 8XG

Registered Number

13305220 (England and Wales)
ROSE TREE SURGEONS LIMITED
Balance Sheet as at
31 March 2023

Notes

2023

2022

£

£

£

£

Fixed assets
Tangible assets65,80560,330
65,80560,330
Current assets
Debtors547,55224,669
Cash at bank and on hand12,2828,067
59,83432,736
Creditors amounts falling due within one year6(27,324)(55,852)
Net current assets (liabilities)32,510(23,116)
Total assets less current liabilities98,31537,214
Creditors amounts falling due after one year7(14,248)-
Net assets84,06737,214
Capital and reserves
Called up share capital100100
Profit and loss account83,96737,114
Shareholders' funds84,06737,214
The financial statements were approved and authorised for issue by the Board of Directors on 22 September 2023, and are signed on its behalf by:
ROSE, Dominic
Director
Registered Company No. 13305220
ROSE TREE SURGEONS LIMITED
Notes to the Financial Statements
for the year ended 31 March 2023

1.Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
2.Compliance with applicable reporting framework
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
3.Accounting policies
Revenue recognition policy
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation and operations policy
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
4.Employee information

20232022
Average number of employees during the year00
5.Debtors

2023

2022

££
Trade debtors / trade receivables31,46622,387
Other debtors11,803-
Prepayments and accrued income4,2832,282
Total47,55224,669
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
6.Creditors within one year

2023

2022

££
Trade creditors / trade payables4,9003,506
Bank borrowings and overdrafts-36,232
Taxation and social security21,11014,974
Accrued liabilities and deferred income1,3141,140
Total27,32455,852
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
7.Creditors after one year

2023

2022

££
Bank borrowings and overdrafts14,248-
Total14,248-